SANIONA AB competitors & alternatives

Symphogen (part of Servier)Biotechnology / PharmaceuticalsSweden

65% match

Biotechnology / Pharmaceuticals

Symphogen, part of the Servier Group, operates as an Antibody Center of Excellence focusing on oncology and immuno-oncology. The company utilizes an antibody discovery and research platform to develop monoclonal antibody therapeutics aimed at improving treatments for cancer patients.

OREXO AB OREXO0H19 · PharmaceuticalsUnited Kingdom

64% matchPublic

Similar pharmaceuticals company

Orexo AB is a pharmaceutical company that specializes in developing innovative drug delivery technologies, notably its powder-based AmorphOX platform. The company advances proprietary and partnered pharmaceutical products, including treatments, vaccines, and nasal delivery formulations, serving patients and healthcare partners globally.

Similar pharmaceuticals company

Suven Life Sciences Limited operates as a clinical-stage biopharmaceutical enterprise dedicated to the identification, progression, and commercialization of innovative therapeutic solutions. Its primary focus lies in addressing neurodegenerative conditions across key markets including India, the United States, Europe, and other international territories. The company's core activities revolve around the discovery and subsequent development of new chemical entities (NCEs) specifically targeting disorders of the central nervous system (CNS). Among its promising pipeline assets are SUVN-502, intended for Alzheimer's disease and associated neuropsychiatric manifestations; SUVN-G3031, a potent and selective inverse agonist of the histamine H3 receptor, aimed at sleep and cognitive impairments; and SUVN-911, a novel, potent, and selective a4ß2 nicotinic acetylcholine receptor antagonist designed to alleviate depressive disorders. Further advancing its portfolio, Suven is also working on SUVN-D4010, a potent, selective, orally bioavailable, and brain-penetrant partial agonist of the 5-HT4 receptor for cognitive dysfunctions; SUVN-I6107, addressing cognitive issues and schizophrenia; SUVN-M8036 for various psychiatric ailments; and SUVN-D1044, targeting gastrointestinal conditions. Established in 1989, the company is based in Hyderabad, India. It adopted its current name, Suven Life Sciences Limited, in 2003, having previously operated as Suven Pharmaceuticals Pvt. Ltd. Jasti Property and Equity Holdings Private Limited holds a controlling interest in Suven Life Sciences Limited, making it a subsidiary.

Similar pharmaceuticals company

Abital Pharma Pipelines is an incubator in Israel dedicated to advancing life science innovation. The company collaborates with the Naiot incubator to develop drugs targeting the central nervous system.

Healthcare

Salipro Biotech AB is a privately held biotechnology company headquartered in Stockholm, Sweden. The company is focused on unlocking challenging drug targets to advance drug discovery and develop next-generation therapeutics.

Rapport Therapeutics, Inc.RAPP · BiotechBoston, United States

66% matchPublicAI 4/100Green 0/100

Biotech

Rapport Therapeutics, Inc. functions as a clinical-phase biopharmaceutical enterprise, concentrating its efforts on discovering and developing innovative small-molecule therapeutics for individuals living with central nervous system (CNS) disorders. Its flagship product candidate, RAP-219, is an experimental small molecule precisely designed to inhibit TARPy8-containing AMPARs with exceptional potency (picomolar affinity). This promising compound aims to treat focal epilepsy and a range of other neurological conditions, including peripheral neuropathic pain and bipolar disorder. The company's pipeline further includes RAP-199, another molecule targeting TARPy8, which boasts distinct chemical and pharmacokinetic profiles. Moreover, Rapport is advancing several nicotinic acetylcholine receptor (nAChR) programs, such as an a6 nAChR therapy for chronic pain and an a9a10 nAChR treatment intended for hearing impairments. Formed in 2022 under the initial name Precision Neuroscience NewCo, Inc., the company adopted its current identity as Rapport Therapeutics, Inc. in October 2022, and its operations are based in Boston, Massachusetts.

HealxBiotech

65% match

Biotech

Healx is an AI-native pharmaceutical company that uses artificial intelligence and technology to discover and develop new treatments for rare diseases. The company redevelops, combines, and enhances known compounds to build a drug pipeline aimed at delivering effective therapies to patients.

Affibody ABBiotechnologySweden

65% match

Biotechnology

Affibody AB is a Swedish biopharmaceutical company located in Solna that develops next-generation biopharmaceuticals based on its proprietary Affibody technology platform.

Biotechnology

Carmot Therapeutics, Inc. is a biopharmaceutical company headquartered in Berkeley, California, focused on discovering and developing innovative treatments for metabolic diseases and obesity.

Maxion TherapeuticsBiotechUnited Kingdom

64% match

Biotech

Maxion Therapeutics is a biotechnology company headquartered in Cambridge, England, utilizing proprietary KnotBody technology to discover and develop first-in-class protein therapeutics.

Cajal NeuroscienceLife SciencesUnited States

64% match

Life Sciences

Cajal Neuroscience (Cajal Therapeutics Inc.) is a biotechnology company headquartered in Seattle, Washington. The company is dedicated to advancing therapeutic pipelines in neuroscience research.

Gate2BrainBiotechnologySpain

64% matchPrivate

Biotechnology

Gate2Brain is a biotechnology company dedicated to developing therapeutics that can efficiently cross biological barriers, such as the blood-brain barrier. It was founded as a spin-off from IRB Barcelona, the University of Barcelona, and Hospital Sant Joan de Déu.